NCT02883556
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Neoplasms, +3 more
- Locations
-
- Hôpital Avicenne Bobigny, France
Clinical trial condition
Neoplasms, Squamous Cell
Explore clinical trials studying Neoplasms, Squamous Cell. Study availability and eligibility vary by location and protocol.
815 public trials
209 recruiting studies
Neoplasms, Squamous Cell trial results
NCT01598077
- Conditions
- Breast Diseases, Breast Neoplasms, Carcinoma, +22 more
- Locations
-
- University of Chicago Medical Center University of Chicago (16) Chicago, Illinois, United States
- Massachusetts General Hospital SC-5 Boston, Massachusetts, United States
- University of Texas/MD Anderson Cancer Center UT MD Houston, Texas, United States
- University of Utah / Huntsman Cancer Institute Huntsman Salt Lake City, Utah, United States
NCT01822613
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- University of Chicago Medical Center Dept of Onc Chicago, Illinois, United States
- Karmanos Cancer Institute Dept of Onc Detroit, Michigan, United States
- University of Texas/MD Anderson Cancer Center Gastrointestinal Med. Oncology Houston, Texas, United States
- Novartis Investigative Site Brussels, Belgium
NCT02580916
- Conditions
- Basal Cell Carcinoma, Carcinoma, Carcinoma, Basal Cell, +12 more
- Locations
-
- Churchill Hospital Headington, Oxford, United Kingdom
- Conditions
- Adenocarcinoma Of Esophagus, Barrett Esophagus, Carcinoma, +24 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT01107639
- Conditions
- Adenocarcinoma Of Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Carcinoma, +15 more
- Locations
-
- Landeskrankenhaus Feldkirch, Austria
- Universitätsklinik für Innere Medizin I Innsbruck, Austria
- Krankenhaus Barmherzige Schwestern Linz Linz, Austria
- Krankenhaus der Elisabethinen Linz GmbH Linz, Austria
NCT02606916
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Sun yat-sen University Cancer Center Guangzhou, Guangdong, China
NCT00833261
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Carcinoma, Verrucous, +21 more
- Locations
-
- University Hospitals of Cleveland Cleveland, Ohio, United States
- Baylor Research Institute Dallas, Texas, United States
- University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States
- Medical College of Wisconsin Milwaukee, Wisconsin, United States
Completed
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
NCT02658214
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +58 more
- Locations
-
- Research Site Chūōku, Japan
- Research Site Kashiwa, Japan
- Research Site Seoul, South Korea
- Research Site Seoul, South Korea
NCT02776137
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
- Locations
-
- Shanghai ninth people's hospital Shanghai, Shanghai Municipality, China